The Asia Pacific cartilage degeneration market is expected to reach US$ 2,509.24 million by 2027 from US$ 1,721.26 million in 2019; it is estimated to grow at a CAGR of 5.0% from 2020 to 2027.
Increasing prevalence of sports injuries and obesity in the region are the key factors driving the growth of cartilage degeneration. However high cost of cartilage therapies is the major factor hindering the market growth in Asia Pacific.Cartilage plays an important role in smooth mechanical movements of bones and muscles. Degeneration of cartilage can lead to pain and chronic inflammation in joints. Furthermore, this damaged cartilage can potentially influence quality of the life. Continual research and development is leading to innovation of new techniques and methodologies to deal with damages cartilages. Some of these techniques comprises joint replacement, cell therapies, and chondroplasty amongst others.
Athletes and players frequently suffer due to injuries during sports activities. These injuries have significant potential to damage cartilage and ligaments. An increasing number of sports injuries among players and athletes is anticipated to drive the growth of the cartilage degeneration market during the forecast period. For instance, the summer Asian games in 2010, in Guangzhou, reported an overall of 725 injuries in 430 athletes. 288 of which were newly incurred in 209 athletes at an incidence rate of 45.5 injuries per 1,000 athletes’ exposure. In Australia, soccer is the most played sport, and between 2011–2012, more than 3,000 athletes were admitted to hospitals from more than 13,000 clubs, with 22 members per team. During the same period, an overall of more than 36,000 Australians aged 15 or above, were hospitalized due to sports injuries.
The increasing number of participations in sports leads to the surge in sports injuries among the participants, which will eventually drive the growth of the cartilage degeneration market by 2027. Additionally, 4.69% of the Indian population are playing soccer/football daily. Also, about two thirds of the injuries are reported in soccer, handball, basketball, and volleyball. Maximum injured site in footballers is found to be the region of ankle (29.62%) followed by knee (17.59%), shoulder (13.88%), groin (7.40%), hamstring (5.55%), hand (3.70%), and others (12.96%). Such increasing number of sports participations is projected to drive the prevalence of cartilage injuries, which will eventually accelerate the growth of the cartilage regeneration market during the forecast period.
Countries in Asia Pacific are facing challenges due to increasing incidences of COVID-19. In an effort to relieve healthcare systems, many clinics have been postponing non-critical surgeries. To avoid overburdening hospitals already struggling to deal with the rising pandemic pressure, doctors are delaying surgeries till the Covid-19 peak is past. Many big medical device companies such as Stryker, CartiHeal Inc., and Smith & Nephew have predicated the decline in sales in china. Almost no elective surgeries were performed in China in February. China is a rapidly growing market for devices like hip and knee implants and contribute hugely to total revenue of many companies.
Rest of Asia Pacific Cartilage Degeneration Market, Revenue and Forecast to 2027 (US$ Mn)
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
ASIA PACIFIC CARTILAGE DEGENERATION MARKET SEGMENTATION
By Procedure Type
- Joint Replacement
- Chondroplasty
- Cell-based Cartilage Resurfacing
- Osteochondral Transplant
- Meniscus Transplants
- Others
By Application
- Knee
- Hips
- Other
By End User
- Hospitals and Specialty Clinics
- Ambulatory Surgical Centers
- Academic and Research Institutes
By Country
- China
- Japan
- India
- South Korea
- Australia
Company Profiles
- B. Braun Melsungen AG
- Smith & Nephew
- Stryker Corporation
- CartiHeal, Inc
- Vericel Corporation
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Procedure Type, Application, and End User and Country
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Australia, China, Japan, South Korea
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Asia Pacific Cartilage Degeneration Market – By Procedure Type
1.3.2 Asia Pacific Cartilage Degeneration Market – By Application
1.3.3 Asia Pacific Cartilage Degeneration Market– By End User
1.3.4 Asia Pacific Cartilage Degeneration Market – By Country
2. Asia Pacific Cartilage Degeneration Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Cartilage Degeneration Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Cartilage Degeneration Market - Asia Pacific PEST Analysis
4.3 Expert Opinion
5. Asia Pacific Cartilage Degeneration Market - Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Growing Number of Sports Injuries
5.1.2 Increasing Prevalence of Obesity
5.2 Key Market Restraints
5.2.1 High Cost of Cartilage Repair Therapies
5.3 Key Market Opportunities
5.3.1 Growing Number of Product Approvals and Developments
5.4 Future Trends
5.4.1 Rising Emphasis on Regenerative Medicines
5.5 Impact analysis
6. Cartilage Degeneration Market – Asia Pacific Analysis
6.1 Asia Pacific Cartilage Degeneration Market Revenue Forecasts and Analysis
7. Asia Pacific Cartilage Degeneration Market Analysis and Forecasts To 2027 – By Procedure Type
7.1 Overview
7.2 Asia Pacific Cartilage Degeneration Market, By Procedure Type 2019 & 2027 (%)
7.2.1 Asia Pacific Cartilage Degeneration Market Revenue and Forecasts to 2027, By Procedure Type (US$ Mn)
7.3 Osteochondral Transplant
7.3.1 Overview
7.3.2 Asia Pacific Osteochondral Transplant Market Revenue and Forecast to 2027 (US$ Mn)
7.4 Chondroplasty
7.4.1 Overview
7.4.2 Asia Pacific Chondroplasty Market Revenue and Forecasts to 2027 (US$ Mn)
7.5 Joint Replacement
7.5.1 Overview
7.5.2 Asia Pacific Joint Replacement Market Revenue and Forecast to 2027 (US$ Mn)
7.6 Meniscus Transplants
7.6.1 Overview
7.6.2 Asia Pacific Meniscus Transplants Market Revenue and Forecast to 2027 (US$ Mn)
7.7 Cell-based Cartilage Resurfacing
7.7.1 Overview
7.7.2 Asia Pacific Cell-based Cartilage Resurfacing Market Revenue and Forecast to 2027 (US$ Mn)
7.8 Other Procedures
7.8.1 Overview
7.8.2 Asia Pacific Other Procedures Market Revenue and Forecast to 2027 (US$ Mn)
8. Asia Pacific Cartilage Degeneration Market Analysis and Forecasts To 2027 – By Application
8.1 Overview
8.2 Asia Pacific Cartilage Degeneration Market, By Application 2019 & 2027 (%)
8.2.1 Asia Pacific Cartilage Degeneration Market Revenue and Forecasts to 2027, By Application (US$ Mn)
8.3 Knee
8.3.1 Overview
8.3.2 Asia Pacific Knee Market Revenue and Forecast to 2027 (US$ Mn)
8.4 Hip
8.4.1 Overview
8.4.2 Asia Pacific Hip Market Revenue and Forecasts to 2027 (US$ Mn)
8.5 Other Applications
8.5.1 Overview
8.5.2 Asia Pacific Other Applications Market Revenue and Forecasts to 2027 (US$ Mn)
9. Asia Pacific Cartilage Degeneration Market Analysis – By End-User
9.1 Overview
9.2 Asia Pacific Cartilage Degeneration Market, By End-User 2019-2027 (%)
9.2.1 Asia Pacific Cartilage Degeneration Market Revenue and Forecasts to 2027, By End-User (US$ Mn)
9.3 Hospitals and Specialty Centres
9.3.1 Overview
9.3.2 Asia Pacific Hospitals and Specialty Centres Market Revenue and Forecasts to 2027 (US$ Mn)
9.4 Ambulatory Surgical Centres
9.4.1 Overview
9.4.2 Asia Pacific Ambulatory Surgical Centres Market Revenue and Forecasts to 2027 (US$ Mn)
9.5 Academic and Research Institutes
9.5.1 Overview
9.5.2 Asia Pacific Academic and Research Institutes Market Revenue and Forecasts to 2027 (US$ Mn)
10. Cartilage Degeneration Market Revenue and Forecasts To 2027 – Geographical Analysis
10.1 Asia Pacific Cartilage Degeneration Market Revenue and Forecasts To 2027
10.1.1 Overview
10.1.2 Asia Pacific: Cartilage Degeneration Market - Revenue and Forecast to 2027 (USD Million)
10.1.3 Asia Pacific: Cartilage Degeneration Market, by Procedure Type – Revenue and Forecast to 2027 (USD Million)
10.1.4 Asia Pacific: Cartilage Degeneration Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.1.5 Asia Pacific: Cartilage Degeneration Market, End User – Revenue and Forecast to 2027 (USD Million)
10.1.6 Asia Pacific: Cartilage Degeneration Market, by Country, 2019 & 2027 (%)
10.1.7 China: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.1 China: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.2 China: Cartilage Degeneration Market, by Procedure Type – Revenue and Forecast to 2027 (USD Million)
10.1.7.3 China: Cartilage Degeneration Market, by Application– Revenue and Forecast to 2027 (USD Million)
10.1.7.4 China: Cartilage Degeneration Market, End User – Revenue and Forecast to 2027 (USD Million)
10.1.8 Japan: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.1 Japan: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.2 Japan: Cartilage Degeneration Market, by Procedure Type – Revenue and Forecast to 2027 (USD Million)
10.1.8.3 Japan: Cartilage Degeneration Market, by Application– Revenue and Forecast to 2027 (USD Million)
10.1.8.4 Japan: Cartilage Degeneration Market, End User – Revenue and Forecast to 2027 (USD Million)
10.1.9 India: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.1 India: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.2 India: Cartilage Degeneration Market, by Procedure Type – Revenue and Forecast to 2027 (USD Million)
10.1.9.3 India: Cartilage Degeneration Market, by Application– Revenue and Forecast to 2027 (USD Million)
10.1.9.4 India: Cartilage Degeneration Market, End User – Revenue and Forecast to 2027 (USD Million)
10.1.10 South Korea: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)
10.1.10.1 South Korea: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)
10.1.10.2 South Korea: Cartilage Degeneration Market, by Procedure Type – Revenue and Forecast to 2027 (USD Million)
10.1.10.3 South Korea: Cartilage Degeneration Market, by Application– Revenue and Forecast to 2027 (USD Million)
10.1.10.4 South Korea: Cartilage Degeneration Market, End User – Revenue and Forecast to 2027 (USD Million)
10.1.11 Australia: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)
10.1.11.1 Australia: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)
10.1.11.2 Australia: Cartilage Degeneration Market, by Procedure Type – Revenue and Forecast to 2027 (USD Million)
10.1.11.3 Australia: Cartilage Degeneration Market, by Application– Revenue and Forecast to 2027 (USD Million)
10.1.11.4 Australia: Cartilage Degeneration Market, End User – Revenue and Forecast to 2027 (USD Million)
11. Impact of COVID-19 Pandemic on Asia Pacific Cartilage degeneration Market
11.1 Asia Pacific: Impact Assessment of COVID-19 Pandemic
12. Company Profiles
12.1 B. Braun Melsungen AG
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Smith & Nephew
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Stryker Corporation
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 CartiHeal, Inc.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Vericel Corporation
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. Asia Pacific Cartilage Degeneration Market Revenue and Forecasts To 2027, By Procedure Type (US$ Mn)
Table 2. Asia Pacific Cartilage Degeneration Market Revenue and Forecasts To 2027, By Application (US$ Mn)
Table 3. Asia Pacific Cartilage Degeneration Market Revenue and Forecasts To 2027, By End-User (US$ Mn)
Table 4. Asia Pacific: Cartilage Degeneration Market, by Procedure Type – Revenue and Forecast to 2027 (USD Million)
Table 5. Asia Pacific: Cartilage Degeneration Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 6. Asia Pacific: Cartilage Degeneration Market, End User – Revenue and Forecast to 2027 (USD Million)
Table 7. China: Cartilage Degeneration Market, by Procedure Type – Revenue and Forecast to 2027 (USD Million)
Table 8. China: Cartilage Degeneration Market, by Application – Revenue and Forecast to 2027 (USD Million).
Table 9. China: Cartilage Degeneration Market, End User – Revenue and Forecast to 2027 (USD Million)
Table 10. Japan: Cartilage Degeneration Market, by Procedure Type – Revenue and Forecast to 2027 (USD Million)
Table 11. Japan: Cartilage Degeneration Market, by Application – Revenue and Forecast to 2027 (USD Million).
Table 12. Japan: Cartilage Degeneration Market, End User – Revenue and Forecast to 2027 (USD Million)
Table 13. India: Cartilage Degeneration Market, by Procedure Type – Revenue and Forecast to 2027 (USD Million)
Table 14. India: Cartilage Degeneration Market, by Application – Revenue and Forecast to 2027 (USD Million).
Table 15. India: Cartilage Degeneration Market, End User – Revenue and Forecast to 2027 (USD Million)
Table 16. South Korea: Cartilage Degeneration Market, by Procedure Type – Revenue and Forecast to 2027 (USD Million)
Table 17. South Korea: Cartilage Degeneration Market, by Application – Revenue and Forecast to 2027 (USD Million).
Table 18. South Korea: Cartilage Degeneration Market, End User – Revenue and Forecast to 2027 (USD Million)
Table 19. Australia: Cartilage Degeneration Market, by Procedure Type – Revenue and Forecast to 2027 (USD Million)
Table 20. Australia: Cartilage Degeneration Market, by Application – Revenue and Forecast to 2027 (USD Million).
Table 21. Australia: Cartilage Degeneration Market, End User – Revenue and Forecast to 2027 (USD Million)
Table 22. Glossary of Terms, Cartilage Degeneration Market
LIST OF FIGURES
Figure 1. Cartilage Degeneration Market Segmentation
Figure 2. Asia Pacific Cartilage Degeneration Market Overview
Figure 3. Knee Segment Held Largest Share of Cartilage Degeneration Market
Figure 4. Japan is Expected to Show Remarkable Growth During the Forecast Period
Figure 5. Asia Pacific Cartilage Degeneration Market - Leading Country Markets (US$ Mn)
Figure 6. Cartilage Degeneration Market - Asia Pacific PEST Analysis
Figure 7. Cartilage Degeneration Market Impact Analysis of Driver and Restraints
Figure 8. Asia Pacific Cartilage Degeneration Market – Revenue Forecasts and Analysis – 2019- 2027
Figure 9. Asia Pacific Cartilage Degeneration Market, By Procedure Type 2019 & 2027 (%)
Figure 10. Asia Pacific Osteochondral Transplant Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 11. Asia Pacific Chondroplasty Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 12. Asia Pacific Joint Replacement Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 13. Asia Pacific Meniscus Transplants Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 14. Asia Pacific Cell-based Cartilage Resurfacing Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 15. Asia Pacific Other Procedures Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 16. Asia Pacific Cartilage Degeneration Market, By Application 2019 & 2027 (%)
Figure 17. Asia Pacific Knee Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 18. Asia Pacific Hip Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 19. Asia Pacific Other Applications Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 20. Asia Pacific Cartilage Degeneration Market, by End-User 2019 & 2027 (%)
Figure 21. Asia Pacific Hospitals and Specialty Centres Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 22. Asia Pacific Ambulatory Surgical Centres Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 23. Asia Pacific Academic and Research Institutes Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 24. Asia Pacific: Cartilage Degeneration Market, by Key Country – Revenue (2019) (USD Million)
Figure 25. Asia Pacific: Cartilage Degeneration Market Revenue and Forecast to 2027 (USD Million)
Figure 26. Asia Pacific: Cartilage Degeneration Market, by Country, 2019 & 2027 (%)
Figure 27. China: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)
Figure 28. Japan: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)
Figure 29. India: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)
Figure 30. South Korea: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)
Figure 31. Australia: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)
Figure 32. Impact of COVID-19 Pandemic in Asia-Pacific Country Markets
The List of Companies - Asia Pacific Cartilage Degeneration Market
- B. Braun Melsungen AG
- Smith & Nephew
- Stryker Corporation
- CartiHeal, Inc
- Vericel Corporation
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Asia Pacific Cartilage Degeneration Market
Sep 2020
Colonoscopes Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Fiber Optic Colonoscopy Devices, Video Colonoscopy Devices); Application (Colorectal Cancer, Lynch Syndrome, Ulcerative Colitis, Crohn's Disease, Polyp); End User (Hospitals, Ambulatory Surgery Center, Others), and Geography
Sep 2020
Noninvasive Fat Reduction Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Cryolipolysis, Laser Lipolysis, Ultrasound, and Others), End User (Hospitals, Dermatology Clinics & Cosmetic Clinics, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2020
Medical Ultrasound Flow Meter Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Implementation Type (Clamp-On, Inline, and Others), Technology (Doppler, Transit Time, and Hybrid), Application (Heart and Lung Machines, Extracorporeal Membrane Oxygenation, Perfusion, Organ Transportation Systems, and Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers, Research Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2020
Rapid Test Kits Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Rapid Antigen Testing, Rapid Antibody Testing, and Others), Product (Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit), Technology (Lateral Flow Assay, Solid Phase, Agglutination, Immunospot Assay, and Cellular Component-Based), Application (Blood Glucose Testing, Infectious Disease Testing, Pregnancy and Fertility, Cardiometabolic Testing, and Others), End User (Hospital and Clinics, Home Care, Diagnostics Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2020
Osteoarthritis Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type [Transcutaneous Electrical Nerve Stimulation (TENS), Occupational Therapy, Physical Therapy, Platelet-Rich Plasma Therapy and Stromal Vascular Fraction, Prolotherapy, and Others], Disease Indication (Knee Osteoarthritis, Spine Osteoarthritis, Foot and Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis, and Others), End User (Hospitals & Clinics, Specialty Clinics, Ambulatory Surgical Centers, Homecare, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2020
Bariatric Surgeries Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type [Adjustable Gastric Bands (AGB), Sleeve Gastrectomy, Gastric Bypass, Biliopancreatic Diversion with Duodenal Switch (BPD-DS), and Others], End User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2020
Post-Acute Care Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Service Type (Skilled Nursing Facilities, Inpatient Rehabilitation Facilities, Long-Term Care Hospitals, Home Health Agency, and Others), Age (Elderly, Adult, and Others), Disease Conditions (Amputations, Wound Management, Brain Injury and Spinal Cord Injury, Neurological Disorders, and Others), and Geography
Sep 2020
Lung Cancer Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Therapy Type (Noninvasive and Minimally Invasive), Indication (Non-Small Cell Lung Cancer and Small Cell Lung Cancer), End User (Hospitals, Oncology Clinics, Research Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)